切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - MLK3 - PD-1/PD-L1 interaction - Voltage-gated Potassium (KV) Channels - Androgen Receptors

12件产品中的 1-10

页面
每页
清除全部
  1. PD-1/PD-L1 inhibitor 2
    B6023 PD-1/PD-L1 inhibitor 2
    Target: PD-1/PD-L1 interaction
    Summary: PD-1/PD-L1相互作用的抑制剂
      ≥42 mg/mL
      insoluble in H2O
  2. ODM-201
    A8452 ODM-201
    中文名: 达洛鲁胺
    Target: Androgen Receptors
    Summary: 新一代雄激素受体抑制剂
      ≥19.95 mg/mL
      insoluble in H2O
  3. URMC-099
    B4877 URMC-099
    Target: MLK3
    Summary: MLK3抑制剂
      ≥21.1 mg/mL
      insoluble in H2O
  4. Psora 4
    B7659 Psora 4
     1 Citation
    Target: Voltage-gated Potassium (KV) Channels
    Summary: Kv1.3阻断剂
      ≥15.75 mg/mL
      insoluble in H2O
  5. DL-Adrenaline
    B1326 DL-Adrenaline
    中文名: DL-肾上腺素
    Target: Androgen Receptors
    Summary: 肾上腺素能受体激动剂
      ≥18.3 mg/mL
  6. Ibutilide Fumarate
    B2278 Ibutilide Fumarate
    中文名: 富马酸伊布利特
    Target: Voltage-gated Potassium (KV) Channels|Voltage-gated Calcium Channels (CaV)|sodium channel
    Summary: III类抗心律失常药物
      ≥25.6 mg/mL
      ≥16.4 mg/mL
  7. Cisapride
    B1198 Cisapride
    Target: Voltage-gated Potassium (KV) Channels|5-HT4 Receptor
    Summary: 5-HT4受体激动剂
      ≥23.3 mg/mL
      insoluble in H2O
  8. TOK-001
    A8623 TOK-001
    中文名: 加来特龙,伽来特隆
    Target: Androgen Receptors|Cytochrome P450 (CYP450)
    Summary: CYP17抑制剂和雄激素受体(AR)拮抗剂
      ≥12.4 mg/mL
      insoluble in H2O
  9. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  10. Andarine
    A2150 Andarine
    Target: Androgen Receptors
    Summary: 雄激素受体拮抗剂
      ≥21 mg/mL
      insoluble in H2O

12件产品中的 1-10

页面
每页